2.58

8.83% -0.25

After Hours: 2.41 -0.17 -6.59%

Indaptus Therapeutics Inc (INDP)

Overview News Price History Financials Discussions Forecast

Indaptus Therapeutics Inc stock is traded at $2.58, with a volume of 1.89M. It is down -8.83% in the last 24 hours and down -68.69% over the past month. Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Previous Close:

$2.83

Open:

$2.83

24h Volume:

1.89M

Relative Volume:

0.32

Market Cap:

$2.85M

Revenue:

Net Income/Loss:

$-15.42M

P/E Ratio:

-1.4022

EPS:

-1.84

Net Cash Flow:

$-13.41M

1W Performance:

-21.89%

1M Performance:

-68.69%

6M Performance:

+207.14%

1Y Performance:

+68.63%

1-Day Range:

$2.37

$2.85

1-Week Range:

$2.34

$3.81

52-Week Range:

$0.2701

$13.40

Indaptus Therapeutics Inc Stock (INDP) Company Profile

Name

Indaptus Therapeutics Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(646) 427-2727

Address

3 COLUMBUS CIRCLE, NEW YORK

Employee

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

INDP's Discussions on Twitter

Compare INDP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INDP Indaptus Therapeutics Inc	2.58	2.82M	0	-15.42M	-13.41M	-1.84
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Indaptus Therapeutics Inc (INDP)

Indaptus Therapeutics Inc Stock (INDP) Company Profile

Compare INDP with other stocks

Indaptus Therapeutics Inc Stock (INDP) Latest News

Leading vs lagging indicators on Indaptus Therapeutics Inc. performanceFed Meeting & Safe Capital Allocation Plans - Newser

Published on: 2025-09-12 18:49:19 - Newser

Custom strategy builders for tracking Indaptus Therapeutics Inc.Earnings Growth Summary & Long-Term Safe Investment Plans - Newser

Reversal indicators forming on Indaptus Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser

Can Indaptus Therapeutics Inc. recover in the next quarterJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser

Key metrics from Indaptus Therapeutics Inc.’s quarterly data2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - Newser

Multi factor analysis applied to Indaptus Therapeutics Inc.July 2025 Highlights & Verified Short-Term Plans - Newser

What to do if you’re stuck in Indaptus Therapeutics Inc.Weekly Loss Report & Low Drawdown Investment Ideas - Newser

Is Indaptus Therapeutics Inc. forming a bottoming baseJuly 2025 WrapUp & Daily Volume Surge Signals - Newser

using portfolio simulators with indaptus therapeutics inc. includedMarket Performance Recap & Weekly Stock Performance Updates - Newser

Indaptus Therapeutics Inc. stock momentum explained2025 Analyst Calls & Low Volatility Stock Suggestions - Newser

Published on: 2025-09-12 05:38:46 - Newser

Using portfolio simulators with Indaptus Therapeutics Inc. includedJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser

Evaluating Indaptus Therapeutics Inc. with trendline analysis2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser

Will Indaptus Therapeutics Inc. stock go up soonEarnings Overview Summary & Real-Time Chart Pattern Alerts - Newser

Published on: 2025-09-12 00:32:46 - Newser

Published on: 2025-09-12 00:17:00 - Newser

How to monitor Indaptus Therapeutics Inc. with trend dashboardsMarket Risk Analysis & Consistent Return Strategy Ideas - Newser

Day 7 of Loss Streak for Indaptus Therapeutics Stock with -61% Return (vs. -89% YTD) [9/10/2025] - Trefis

Applying big data sentiment scoring on Indaptus Therapeutics Inc.Market Activity Report & Weekly Chart Analysis and Guides - Newser

Using RSI to spot recovery in Indaptus Therapeutics Inc.July 2025 Technicals & High Conviction Buy Zone Alerts - Newser

Indaptus Therapeutics Inc. stock prediction for this weekQuarterly Profit Summary & Low Risk Entry Point Tips - Newser

How to recover losses in Indaptus Therapeutics Inc. stockJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser

Tick level data insight on Indaptus Therapeutics Inc. volatility2025 Market Overview & Accurate Buy Signal Alerts - Newser

Is Indaptus Therapeutics Inc. stock undervalued right nowPortfolio Return Report & Fast Entry and Exit Trade Plans - Lancaster City Council

Is Indaptus Therapeutics Inc. stock good for income investorsJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Lancaster City Council

News impact scoring models applied to Indaptus Therapeutics Inc.Portfolio Update Report & Long-Term Safe Investment Plans - Newser

Is Indaptus Therapeutics Inc. meeting your algorithmic filter criteriaEarnings Trend Report & High Conviction Investment Ideas - Newser

Order flow analysis tools used on Indaptus Therapeutics Inc.2025 Historical Comparison & Growth Focused Investment Plans - Newser

Indaptus Therapeutics Inc.’s volatility index tracking explained2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser

What MACD signals say about Indaptus Therapeutics Inc.Quarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser

Real time alert setup for Indaptus Therapeutics Inc. performance2025 Pullback Review & Pattern Based Trade Signal System - Newser

Published on: 2025-09-08 15:18:14 - Newser

Indaptus Therapeutics Inc Stock (INDP) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to INDP